Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11884624 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +3 more | 2024-01-30 |
| 11066361 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +3 more | 2021-07-20 |
| 10556862 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +3 more | 2020-02-11 |
| 9688627 | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Joseph Michael Colombo, Bradlee David Germain, Gregory William Endres, Andriy Komilov +5 more | 2017-06-27 |
| 9676712 | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Bradlee David Germain, Adam Uzieblo, Fred Lawrence Ciske, Gregory William Endres +3 more | 2017-06-13 |
| 9487478 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +3 more | 2016-11-08 |
| 9180116 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +3 more | 2015-11-10 |
| 8168400 | Methods and kits for detection of thromboxane A2 metabolites | F. Jon Geske, Amy Whittier, Daniel Tew | 2012-05-01 |
| 8105790 | Methods and kits for detection of thromboxane A2 metabolites | F. Jon Geske, Amy Whittier, Daniel Tew | 2012-01-31 |
| 8063240 | Prostaglandin E1 and E2 analogs for the treatment of various medical conditions | Nancy Barta, Stephen Douglas Barrett, Gregory William Endres, Andriy Kornilov, Adam Uzieblo | 2011-11-22 |
| 7972406 | Diesel particulate filter and method of making | Jing Zheng | 2011-07-05 |
| 7727730 | Methods and kits for detection of thromboxane A2 metabolites | F. Jon Geske, Amy Whittier, Daniel Tew | 2010-06-01 |
| 7674921 | Internal 1,15-lactones of fluprostenol and related prostaglandin F2α analogs and their use in the treatment of glaucoma and intraocular hypertension | Michelle L. Stanton | 2010-03-09 |
| 7585889 | Internal 1,15-lactones of fluprostenol and related prostaglandin F2α analogs and their use in the treatment of glaucoma and intraocular hypertension | Michelle L. Stanton | 2009-09-08 |
| 7358275 | Internal 1,15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension | Michelle L. Stanton | 2008-04-15 |
| 4352760 | Organic compounds substituted heptadeca-5,9- and 5,10-dienoic acid | — | 1982-10-05 |